Enveric Biosciences, Inc. (ENVB) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Naples, FL, United States. El CEO actual es Joseph Edward Tucker.
ENVB tiene fecha de IPO 2015-05-04, 5 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $1.16M.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
